Malignant neoplasm of breast
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Metastatic melanoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Adenocarcinoma of large intestine
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Ovarian Mucinous Adenocarcinoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Coloboma of iris
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital coloboma of iris
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital sensorineural hearing loss
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Northern blots demonstrate that mRNA encoding this truncated Ror1 ('t-Rorl') is abundantly expressed in fetal and adult human CNS, in human leukemia, lymphoma cell lines, and in a variety of human cancers derived from neuroectoderm.
|
8875995 |
1996 |
leukemia
|
0.050 |
Biomarker
|
disease |
BEFREE |
Northern blots demonstrate that mRNA encoding this truncated Ror1 ('t-Rorl') is abundantly expressed in fetal and adult human CNS, in human leukemia, lymphoma cell lines, and in a variety of human cancers derived from neuroectoderm.
|
8875995 |
1996 |
Childhood Leukemia
|
0.040 |
Biomarker
|
disease |
BEFREE |
Northern blots demonstrate that mRNA encoding this truncated Ror1 ('t-Rorl') is abundantly expressed in fetal and adult human CNS, in human leukemia, lymphoma cell lines, and in a variety of human cancers derived from neuroectoderm.
|
8875995 |
1996 |
Lymphoma
|
0.020 |
Biomarker
|
group |
BEFREE |
Northern blots demonstrate that mRNA encoding this truncated Ror1 ('t-Rorl') is abundantly expressed in fetal and adult human CNS, in human leukemia, lymphoma cell lines, and in a variety of human cancers derived from neuroectoderm.
|
8875995 |
1996 |
Adult Lymphoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Northern blots demonstrate that mRNA encoding this truncated Ror1 ('t-Rorl') is abundantly expressed in fetal and adult human CNS, in human leukemia, lymphoma cell lines, and in a variety of human cancers derived from neuroectoderm.
|
8875995 |
1996 |
Childhood Lymphoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Northern blots demonstrate that mRNA encoding this truncated Ror1 ('t-Rorl') is abundantly expressed in fetal and adult human CNS, in human leukemia, lymphoma cell lines, and in a variety of human cancers derived from neuroectoderm.
|
8875995 |
1996 |
Teratocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We used a Ror1 cDNA probe to screen a cDNA library prepared from the human neuronogenic teratocarcinoma line, NTera2, and cloned a 2373 nucleotide transcript.
|
8875995 |
1996 |
Malignant tumor of colon
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ROR1 mRNA was expressed in embryonic stem (ES) cells, infant brain, renal cancer, and colon cancer.
|
16211313 |
2005 |
Colon Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ROR1 mRNA was expressed in embryonic stem (ES) cells, infant brain, renal cancer, and colon cancer.
|
16211313 |
2005 |
Malignant neoplasm of kidney
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ROR1 mRNA was expressed in embryonic stem (ES) cells, infant brain, renal cancer, and colon cancer.
|
16211313 |
2005 |
Renal carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ROR1 mRNA was expressed in embryonic stem (ES) cells, infant brain, renal cancer, and colon cancer.
|
16211313 |
2005 |
Chronic Lymphocytic Leukemia
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
The restricted, uniform, and constitutive cell surface expression of ROR1 protein in B-CLL provides a strong incentive for the development of targeted therapeutics such as monoclonal antibodies.
|
18223214 |
2008 |
Chronic Lymphocytic Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
We conclude that patients with CLL can break immune tolerance to ROR1, which is an oncofetal surface antigen and survival-signaling receptor in this neoplastic disease.
|
18287027 |
2008 |
Chronic Lymphocytic Leukemia
|
0.100 |
Biomarker
|
disease |
LHGDN |
We conclude that patients with CLL can break immune tolerance to ROR1, which is an oncofetal surface antigen and survival-signaling receptor in this neoplastic disease.
|
18287027 |
2008 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
We conclude that patients with CLL can break immune tolerance to ROR1, which is an oncofetal surface antigen and survival-signaling receptor in this neoplastic disease.
|
18287027 |
2008 |
leukemia
|
0.050 |
Biomarker
|
disease |
BEFREE |
Five patients made high-titer antibodies against adenovirus and three made IgG reactive with a leukemia-associated surface antigen, which we identified as ROR1.
|
18287027 |
2008 |
Childhood Leukemia
|
0.040 |
Biomarker
|
disease |
BEFREE |
Five patients made high-titer antibodies against adenovirus and three made IgG reactive with a leukemia-associated surface antigen, which we identified as ROR1.
|
18287027 |
2008 |